How does Wellbutrin (bupropion) affect the seizure threshold?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Wellbutrin (Bupropion) and Seizure Threshold

Bupropion is absolutely contraindicated in patients with seizure disorders because it lowers the seizure threshold through its effects on dopaminergic, adrenergic, and nicotinic acetylcholinergic receptor systems, and must be discontinued immediately if a patient experiences a seizure. 1, 2, 3

Mechanism of Seizure Risk

Bupropion reduces the seizure threshold through multiple mechanisms: effects on dopaminergic and adrenergic systems, plus inhibition of nicotinic acetylcholinergic receptors. 1 This pharmacologic action creates dose-dependent seizure risk that increases substantially at higher doses. 3

Absolute Contraindications

Bupropion is contraindicated in all patients with:

  • Any history of seizure disorder 2, 3
  • Conditions that predispose to seizures, including: 1, 3
    • Arteriovenous malformation 1, 3
    • CNS tumor or CNS infection 3
    • Severe head injury 3
    • Severe stroke 3
    • Anorexia nervosa or bulimia (which have documented higher seizure incidence) 1, 3
    • Brain metastases 1

This contraindication applies regardless of formulation—whether prescribed as Wellbutrin for depression, Zyban for smoking cessation, or naltrexone-bupropion ER (Contrave) for obesity. 2

Dose-Dependent Seizure Risk

The seizure incidence varies dramatically by dose: 3, 4

  • At ≤300 mg/day: approximately 0.1% (1/1,000 patients) 3
  • At 300-450 mg/day: approximately 0.4% (4/1,000 patients) 3, 4
  • At 450-600 mg/day: risk increases nearly tenfold 3

The maximum dose must never exceed 450 mg once daily for extended-release formulations. 3

High-Risk Clinical Situations

Use extreme caution or avoid bupropion entirely in patients with: 5, 1, 3

Metabolic Disorders

  • Hypoglycemia 1, 3
  • Hyponatremia 1, 3
  • Severe hepatic impairment 1, 3
  • Hypoxia 1, 3

Diabetes Management

  • Diabetes mellitus treated with oral hypoglycemics or insulin 1, 3

Substance Use/Withdrawal

  • Abrupt discontinuation of alcohol, benzodiazepines, barbiturates, or antiepileptic drugs 3
  • Use of illicit drugs (e.g., cocaine) 3
  • Abuse or misuse of CNS stimulants 3
  • Excessive use of alcohol, benzodiazepines, sedative/hypnotics, or opiates 3

Concomitant Medications That Lower Seizure Threshold

  • Other bupropion products 3
  • Antipsychotics 3, 6
  • Tricyclic antidepressants 3
  • Theophylline 3
  • Systemic corticosteroids 3
  • Clozapine (particularly high risk—clozapine alone has 10% cumulative seizure risk at 3.8 years; combination with bupropion may have additive or synergistic effects) 6

Other Risk Factors

  • Use of anorectic drugs 1, 3
  • Untreated hyperthyroidism (when combined with phentermine formulations) 5

Guideline Recommendations Across Specialties

Multiple specialty societies uniformly recommend avoiding bupropion in seizure-prone patients: 5, 1, 2

  • American Gastroenterological Association: "should be avoided in patients with seizure disorders and used with caution in patients at risk of seizures" 5
  • American Diabetes Association: "contraindicated in patients with uncontrolled hypertension and/or seizure disorders" 5
  • National Comprehensive Cancer Network: explicitly recommends avoiding bupropion in patients with seizure history or elevated seizure risk 1
  • American College of Gastroenterology: bupropion "should not be used in patients with a history of seizures" 2

Clinical Cases and Real-World Evidence

Seizures can occur even in patients without traditional risk factors: 7, 8

  • A 66-year-old woman with no personal or family seizure history developed new-onset seizures 4 days after starting bupropion for smoking cessation 7
  • A 25-year-old woman with no premorbid epilepsy history had a witnessed generalized convulsion at a modest blood level (83 ng/ml) and dose (600 mg/day) 8
  • Three patients developed generalized tonic-clonic seizures within days of starting bupropion 300 mg/day, with two having no seizure history 9

Management Algorithm If Seizure Occurs

If a patient on bupropion experiences a seizure: 2, 3

  1. Discontinue bupropion immediately and do not restart 3
  2. Consider alternative treatments based on indication: 2
    • For depression: SSRIs, mirtazapine, or nortriptyline 2
    • For smoking cessation: nicotine replacement therapy or varenicline 2
    • For obesity: GLP-1 agonists 2

Risk Mitigation Strategies

If bupropion must be used despite risk factors (though generally not recommended): 3

  • Use low initial doses 3
  • Increase dose gradually 3
  • Never exceed 450 mg once daily 3
  • Monitor closely for neuropsychiatric symptoms 3

Critical Pitfall to Avoid

Do not assume safety based on absence of personal seizure history. Case reports demonstrate that new-onset seizures can occur in patients with no personal or family history of seizures, no predisposing neurological conditions, and at therapeutic doses and blood levels. 7, 8, 9 The drug's pharmacologic mechanism of lowering seizure threshold operates independently of pre-existing vulnerability in some patients.

References

Guideline

Bupropion Contraindications in Seizure Disorders

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Bupropion Contraindications and Seizure Risk

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Seizures and bupropion: a review.

The Journal of clinical psychiatry, 1989

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

A case of bupropion-induced seizure.

The Journal of nervous and mental disease, 1986

Research

[Bupropion-induced epileptic seizures].

Revue neurologique, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.